• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > La Merie Publishing
Publisher
Filter

La Merie Publishing Report List

La Merie Business Intelligence was established in 2002 by Ulrich Martin, MD, based on his extensive experience in the biopharmaceutical industry both as a physician specializing in pharmacology and as a co-founder and CEO of a product development biotech company. The focus of our reports and subscription services such as databases and periodicals is directed towards biologs as therapeutics, such as antibodies, proteins, peptides, vaccines and biosimilars. Today we continue to publish reports, but leverage our experience, knowledge and report writing expertise to offer this service to individual customers.

New for 2017!
Filter
Title Search
1 - 25 of 37 Products Sort by Display
The Oncolytic Virus Landscape 2017: An Analysis of Pipeline, Stakeholders, Deals, Industry Trends & Opportunities
Published by
La Merie Publishing
Product code
425869
Published
January 26, 2017
Content info
225 Pages
Price
USD 2400
Sample available
Flat-Rate Access to R&D Database & Reports from La Merie Publishing
Published by
La Merie Publishing
Product code
388958
Published
annual subscription
Content info
 
Price
USD 8470
Sample available
R&D and Business Tracker for Antibody-Drug Conjugates
Published by
La Merie Publishing
Product code
370244
Published
annual subscription
Content info
 
Price
USD 1350
Sample available
R&D and Business Tracker for Bispecific Antibodies
Published by
La Merie Publishing
Product code
370243
Published
annual subscription
Content info
 
Price
USD 1350
Sample available
R&D and Business Tracker for TCR & CAR T-Cells and NK Cells
Published by
La Merie Publishing
Product code
370242
Published
annual subscription
Content info
 
Price
USD 1350
Sample available
*
Published by
La Merie Publishing
Product code
318570
Published
annual subscription
Content info
 
Price
USD 1000
Sample available
R&D Drug Pipeline Database: 1-Year Subscription
Published by
La Merie Publishing
Product code
302689
Published
annual subscription
Content info
 
Price
USD 6600
Sample available
Flat-Rate Subscription to La Merie Publishing Reports & News Services
Published by
La Merie Publishing
Product code
276496
Published
annual subscription
Content info
 
Price
USD 5500
Sample available
*
Published by
La Merie Publishing
Product code
276495
Published
annual subscription
Content info
 
Price
USD 1600
Sample available
*
Published by
La Merie Publishing
Product code
216725
Published
annual subscription
Content info
 
Price
USD 1261
Sample available
*
Published by
La Merie Publishing
Product code
166718
Published
annual subscription
Content info
 
Price
USD 1513
Sample available
Antibody-Drug Conjugate Pipeline Review By Target, Drug, Phase and Company
Published by
La Merie Publishing
Product code
225677
Published
December 19, 2016
Content info
288 Pages
Price
USD 880
Sample available
3 Reports Bundle: Hot Targets for Empowered Antibody and Cell Therapy Technologies
Published by
La Merie Publishing
Product code
408113
Published
December 8, 2016
Content info
202 Pages
Price
USD 1254
Sample available
4 Reports Bundle: Competitor Analysis - Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology
Published by
La Merie Publishing
Product code
408112
Published
December 8, 2016
Content info
319 Pages
Price
USD 1386
Sample available
2 Reports Bundle: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-Cells (Two Reports released in 2016)
Published by
La Merie Publishing
Product code
368816
Published
September 1, 2016
Content info
 
Price
USD 3400
Sample available
B-Cell Maturation Antigen (BCMA): Hot Target for Emerging Treatment Modalities
Published by
La Merie Publishing
Product code
369011
Published
August 31, 2016
Content info
39 Pages
Price
USD 570
Sample available
CD123: A Paradigmatic Target for Immunotherapeutic Treatment Modalities
Published by
La Merie Publishing
Product code
369010
Published
August 31, 2016
Content info
83 Pages
Price
USD 800
Sample available
TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of Technologies Opens Business Opportunities Beyond CD19 CARTs
Published by
La Merie Publishing
Product code
366651
Published
August 7, 2016
Content info
388 Pages
Price
USD 2750
Sample available
*
Published by
La Merie Publishing
Product code
359751
Published
June 9, 2016
Content info
 
Price
USD 3500
Sample available
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update
Published by
La Merie Publishing
Product code
327820
Published
May 25, 2016
Content info
462 Pages
Price
USD 1450
Sample available
T-Cell Redirecting Bispecific Antibodies 2016: A Competitive Landscape Analysis of Stakeholders, Technologies, Pipelines and Deals
Published by
La Merie Publishing
Product code
357780
Published
May 11, 2016
Content info
230 Pages
Price
USD 2400
Sample available
Competitor Analysis: Anti-VEGF/R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis - 2016 Update
Published by
La Merie Publishing
Product code
358307
Published
February 29, 2016
Content info
46 Pages
Price
USD 440
Sample available
RORgamma Modulators 2016: A Comparative Analysis of the Landscape of RORgamma Antagonists and Agonists
Published by
La Merie Publishing
Product code
351304
Published
February 3, 2016
Content info
88 Pages
Price
USD 1050
Sample available
Antibody-Drug Conjugates 2016: Perspectives & Opportunities - A Pipeline, Technology, Stakeholder & Business Analysis
Published by
La Merie Publishing
Product code
294276
Published
November 30, 2015
Content info
470 Pages
Price
USD 2500
Sample available
Engineered TCR and CAR Immunotherapeutics 2015
Published by
La Merie Publishing
Product code
325905
Published
March 13, 2015
Content info
201 Pages
Price
USD 2630
Sample available